5000 participants
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2009-11-10
- Start Date:
- 2001-07-31
Conditions
- Impaired Glucose Tolerance
- Cardiovascular Disease
- Glucose Metabolism Disorders
Interventions
- DRUG
No Results Yet